Neo-adjuvant Pembrolizumab in Vulvar Squamous Cell Carcinoma: a Clinical Proof-of-concept Study

Clinical trial NCT05761132 · UNKNOWN

Trial details

NCT number: NCT05761132
Sponsor: Leiden University Medical Center
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Vulva Cancer Vulva Neoplasm Squamous Cell Cancer

Start date: 2023-04-01
Primary completion: 2025-02-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.